Physician profile
Robert Bilinski
NPI 1538269717
$863.45
in general payments reported to CMS, 2019-2025
10 companies · $29.07 in 2025
The $29.07 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $63.78 · 2022: $86.32 · 2023: $156 · 2024: $133 · 2025: $29.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.73 | 2019-2025 | Jardiance |
| Amgen INC. | $141.97 | 2019 | |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Arexvy |
| Lilly USA, LLC | $116.98 | 2019-2024 | Mounjaro, Zepbound |
| E.R. Squibb & Sons, L.L.C. | $94.67 | 2019-2024 | Camzyos, Eliquis |
| Shield Therapeutics INC | $51.25 | 2024 | |
| Novartis Pharmaceuticals Corporation | $44.84 | 2019 | |
| Novo Nordisk INC | $20.99 | 2019 | |
| Abbott Laboratories | $14.11 | 2023 | Freestyle Libre 2 |
| Allergan, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bilinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.